1-28592578-A-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001193532.3(RAB42):āc.67A>Cā(p.Thr23Pro) variant causes a missense change. The variant allele was found at a frequency of 0.00000328 in 1,218,976 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000013 ( 0 hom., cov: 31)
Exomes š: 0.0000019 ( 0 hom. )
Consequence
RAB42
NM_001193532.3 missense
NM_001193532.3 missense
Scores
2
1
6
Clinical Significance
Conservation
PhyloP100: 4.54
Genes affected
RAB42 (HGNC:28702): (RAB42, member RAS oncogene family) Predicted to enable GDP binding activity; GTP binding activity; and GTPase activity. Predicted to be involved in Ras protein signal transduction. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
TAF12 (HGNC:11545): (TATA-box binding protein associated factor 12) Control of transcription by RNA polymerase II involves the basal transcription machinery which is a collection of proteins. These proteins with RNA polymerase II, assemble into complexes which are modulated by transactivator proteins that bind to cis-regulatory elements located adjacent to the transcription start site. Some modulators interact directly with the basal complex, whereas others may act as bridging proteins linking transactivators to the basal transcription factors. Some of these associated factors are weakly attached while others are tightly associated with TBP in the TFIID complex. Among the latter are the TAF proteins. Different TAFs are predicted to mediate the function of distinct transcriptional activators for a variety of gene promoters and RNA polymerases. TAF12 interacts directly with TBP as well as with TAF2I. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Sep 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.40367606).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAB42 | NM_001193532.3 | c.67A>C | p.Thr23Pro | missense_variant | 1/2 | ENST00000465518.3 | NP_001180461.1 | |
RAB42 | NM_001385188.1 | c.67A>C | p.Thr23Pro | missense_variant | 1/2 | NP_001372117.1 | ||
RAB42 | NM_152304.3 | c.-107+179A>C | intron_variant | NP_689517.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAB42 | ENST00000465518.3 | c.67A>C | p.Thr23Pro | missense_variant | 1/2 | 2 | NM_001193532.3 | ENSP00000491546 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151608Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
2
AN:
151608
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000187 AC: 2AN: 1067260Hom.: 0 Cov.: 31 AF XY: 0.00000198 AC XY: 1AN XY: 503828
GnomAD4 exome
AF:
AC:
2
AN:
1067260
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
503828
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151716Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74162
GnomAD4 genome
AF:
AC:
2
AN:
151716
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
74162
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 18, 2021 | The c.67A>C (p.T23P) alteration is located in exon 1 (coding exon 1) of the RAB42 gene. This alteration results from a A to C substitution at nucleotide position 67, causing the threonine (T) at amino acid position 23 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Benign
DEOGEN2
Benign
T
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
MetaRNN
Benign
T
MutationTaster
Benign
D
PrimateAI
Pathogenic
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at